- Home
- ONMD vs SLGL Comparison
ONMD vs SLGL Comparison
Compare ONMD & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- SLGL
- Stock Information
- Founded
- ONMD 2006
- SLGL 1997
- Country
- ONMD United States
- SLGL Israel
- Employees
- ONMD N/A
- SLGL N/A
- Industry
- ONMD
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- ONMD
- SLGL Health Care
- Exchange
- ONMD Nasdaq
- SLGL Nasdaq
- Market Cap
- ONMD 12.8M
- SLGL 19.3M
- IPO Year
- ONMD N/A
- SLGL 2018
- Fundamental
- Price
- ONMD $0.56
- SLGL N/A
- Analyst Decision
- ONMD
- SLGL Buy
- Analyst Count
- ONMD 0
- SLGL 1
- Target Price
- ONMD N/A
- SLGL $40.00
- AVG Volume (30 Days)
- ONMD 25.4M
- SLGL 24.6K
- Earning Date
- ONMD 05-14-2025
- SLGL 08-15-2025
- Dividend Yield
- ONMD N/A
- SLGL N/A
- EPS Growth
- ONMD N/A
- SLGL N/A
- EPS
- ONMD N/A
- SLGL N/A
- Revenue
- ONMD $532,000.00
- SLGL $12,103,000.00
- Revenue This Year
- ONMD N/A
- SLGL N/A
- Revenue Next Year
- ONMD N/A
- SLGL $31.17
- P/E Ratio
- ONMD N/A
- SLGL N/A
- Revenue Growth
- ONMD N/A
- SLGL 603.66
- 52 Week Low
- ONMD $0.30
- SLGL $3.34
- 52 Week High
- ONMD $1.60
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- ONMD 56.14
- SLGL 54.46
- Support Level
- ONMD $0.34
- SLGL $7.28
- Resistance Level
- ONMD $0.66
- SLGL $7.48
- Average True Range (ATR)
- ONMD 0.09
- SLGL 0.33
- MACD
- ONMD 0.02
- SLGL 0.02
- Stochastic Oscillator
- ONMD 40.17
- SLGL 43.30
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.